Protection conferred by booster vaccine doses in hospitalized patients with COVID-19 during the SARS-CoV-2 Omicron BA.2 and BA.5 epidemics from 2022 to 2023 in Greece

Protection conferred by booster vaccine doses in hospitalized patients with COVID-19 during the SARS-CoV-2 Omicron BA.2 and BA.5 epidemics from 2022 to 2023 in Greece

Background: To estimate the protection that coronavirus disease 2019 (COVID-19) vaccine doses conferred to hospitalized patients with COVID-19 against adverse outcomes and longer length of stay during the Omicron BA.2 and BA.5 subvariant epidemics in Greece. Methods: The study was conducted from Nov...

Full description

Saved in:
Bibliographic Details
Main Authors: Helena C. Maltezou, Maria N. Gamaletsou, Maria Chini, Vasileios Petrakis, Vasiliki Rapti, Theodoros V. Giannouchos, Eleni Karantoni, Konstantinos Kounouklas, Panagiota Stamou, Αmalia Karapanou, Dimitrios Basoulis, Andrianna-Chrysovalanto Verykokkou, Kyriakos Souliotis, Periklis Panagopoulos, Dimitrios Hatzigeorgiou, Garyfalia Poulakou, Konstantinos N. Syrigos, Nikolaos V. Sipsas
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Infectious Medicine
Subjects:
COVID-19
Hospitalization
Booster doses
Risk factors
Adverse outcomes
Online Access:http://www.sciencedirect.com/science/article/pii/S2772431X24000583
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2772431X24000583

Similar Items